|Posted on Wednesday, May 30, 2012 - 4:01 pm: || |
Very interesting. ~73% of patients that got the drug, and 0% of the placebo group....
|Posted on Wednesday, May 30, 2012 - 5:37 pm: || |
That's very interesting. Here's an article that is interesting:
"This research shows NMDA receptors possess a second binding site at which memantine, but not ketamine, can inhibit activity. The research also shows the dramatic effect physiological concentrations of magnesium has on the ability of these drugs to inhibit NMDA receptor activity. Behavioral and cognitive effects of memantine and ketamine are also assessed and compared directly in rat. The effects of memantine and ketamine in rat were found to be similar at the low doses tested and more divergent as dose increased. Furthermore, memantine's effects appeared to be more pronounced and longer-lasting than those of ketamine. "
My son is on a fairly low dose of memantine (10mg for 150 pound 15yo), quite a lot of magnesium and other supplements that support the proper functioning of the NMDA receptor (Taurine, GABA, Vit B6, B12, etc), and between those and glutamate removal from dietary sources, no longer is diagnosed with either mood disorder nor anxiety disorder. Unfortunately, others on both sides of the family are struggling but unwilling or unable to consider radical dietary changes.
|Posted on Wednesday, May 30, 2012 - 6:08 pm: || |
It was posted on this board 6 years ago. Makes you wonder why things are taking so long.
|Posted on Thursday, May 31, 2012 - 6:54 am: || |
Wow! The original link doesn't work. Is this the same study or has it been successfully duplicated? The link I posted was just published at sciencedaily.com & it references a previous study done by a Dr. Zarate. Interesting.
|Posted on Thursday, May 31, 2012 - 9:48 am: || |
Jennifer, here is an alternate link for the original 2006 posting: